{
    "2020-07-22": [
        [
            {
                "time": "",
                "original_text": "医药生物行业日报：生物制品板块领涨医药",
                "features": {
                    "keywords": [
                        "医药",
                        "生物制品",
                        "领涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【兴证海外医药】港美股新股报告合集之泰格医药（3347.HK）：国内领先的临床CRO服务供应商",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "CRO",
                        "临床服务",
                        "领先"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "牛股频频出没！高瓴押注CRO背后的考量",
                "features": {
                    "keywords": [
                        "高瓴",
                        "CRO",
                        "押注",
                        "考量"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第三家! “A+H”两地上市的CRO企业哪家强？",
                "features": {
                    "keywords": [
                        "A+H",
                        "CRO",
                        "上市",
                        "比较"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}